George Anastassov
Director/Board Member bij INCANNEX HEALTHCARE INC.
Vermogen: 3 M $ op 31-03-2024
Profiel
George E.
Anastassov founded AXIM Biotechnologies, Inc. in 2014, where he worked as Chairman from 2019 to 2020, CanChew Biotechnologies LLC in 2012, where he worked as Director from 2012 to 2013, Stichting Sanammad in 2009, where he is working as Director & General Partner from 2009, Sanammad Pharmaceuticals BV in 2014, where he is working as Director & General Partner from 2014, and APIRX Pharmaceuticals USA LLC in 2017, where he worked as Managing Director from 2017 to 2022.
Dr. Anastassov also currently works at Incannex Healthcare, Inc., as Non-Executive Director from 2022 and CanChew License Co., as President, Secretary, Treasurer & Director.
Dr. Anastassov also formerly worked at RYAH Group, Inc., as Director from 2021 to 2022.
Dr. Anastassov received his undergraduate degree from the University of Tennessee and doctorate degree from NYU College of Dentistry.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INCANNEX HEALTHCARE INC.
4.85% | 21-12-2023 | 769 721 ( 4.85% ) | 3 M $ | 31-03-2024 |
Actieve functies van George Anastassov
| Bedrijven | Functie | Begin |
|---|---|---|
| INCANNEX HEALTHCARE INC. | Director/Board Member | 28-06-2022 |
| Stichting Sanammad | Founder | 01-01-2009 |
| Sanammad Pharmaceuticals BV | Founder | 01-01-2014 |
CanChew License Co.
 CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | President | - |
Eerdere bekende functies van George Anastassov
| Bedrijven | Functie | Einde |
|---|---|---|
| RYAH GROUP, INC. | Director/Board Member | 06-12-2022 |
APIRX Pharmaceuticals USA LLC
 APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Founder | 01-01-2022 |
| AXIM BIOTECHNOLOGIES, INC. | Chief Executive Officer | 02-01-2019 |
CanChew Biotechnologies LLC
 CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Founder | - |
Opleiding van George Anastassov
| University of Tennessee | Undergraduate Degree |
| NYU College of Dentistry | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| INCANNEX HEALTHCARE INC. | Health Technology |
| AXIM BIOTECHNOLOGIES, INC. | Health Technology |
| RYAH GROUP, INC. | Technology Services |
| Bedrijven in privébezit | 5 |
|---|---|
CanChew Biotechnologies LLC
CanChew Biotechnologies LLC Pharmaceuticals: OtherHealth Technology CanChew Biotech focuses on the treatment of pain and other medical disorders with the application of chewing gum based cannabis/cannabinoids medical products. The company targets on the R&D and execution of their clinical development plan and subsequently out licensing of their technology. The development focuses on the R&D of the formulation, production and the development of chewing gum based products in their respective fields e.g.: for the treatment of numerous diseases like pain, nausea and vomiting, anorexia, spasticity and various other symptoms. | Health Technology |
| Stichting Sanammad | Miscellaneous |
| Sanammad Pharmaceuticals BV | |
CanChew License Co.
CanChew License Co. Miscellaneous Commercial ServicesCommercial Services CanChew License Co. provides licensing services. The company is headquartered in Reno, NV. | Commercial Services |
APIRX Pharmaceuticals USA LLC
APIRX Pharmaceuticals USA LLC Pharmaceuticals: OtherHealth Technology APIRX Pharmaceuticals USA LLC is located in the US. Part of Incannex Healthcare, Inc., APIRX Pharmaceuticals USA LLC is an American company that provides research, development, and production of prescription pharmaceutical cannabinoid medicines. The company was founded by George E. Anastassov, Lekhram Changoer. APIRX Pharmaceuticals USA was acquired by Incannex Healthcare, Inc. on August 04, 2022 for $30.91 million. | Health Technology |
